Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec;76(6):643-9.
doi: 10.1016/j.ando.2015.10.002. Epub 2015 Nov 14.

Pituitary Gigantism: Causes and Clinical Characteristics

Affiliations
Review

Pituitary Gigantism: Causes and Clinical Characteristics

Liliya Rostomyan et al. Ann Endocrinol (Paris). .

Erratum in

  • Ann Endocrinol (Paris). 2016 Feb;77(1):60

Abstract

Acromegaly and pituitary gigantism are very rare conditions resulting from excessive secretion of growth hormone (GH), usually by a pituitary adenoma. Pituitary gigantism occurs when GH excess overlaps with the period of rapid linear growth during childhood and adolescence. Until recently, its etiology and clinical characteristics have been poorly understood. Genetic and genomic causes have been identified in recent years that explain about half of cases of pituitary gigantism. We describe these recent discoveries and focus on some important settings in which gigantism can occur, including familial isolated pituitary adenomas (FIPA) and the newly described X-linked acrogigantism (X-LAG) syndrome.

Keywords: Adénomes hypophysaires familiaux isolés (FIPA); Aryl hydrocarbon receptor interacting protein gene; Familial isolated pituitary adenoma (FIPA); Gigantism; Gigantisme; Syndrome d’acrogigantisme lié au chromosome X (X-LAG); X-linked Acrogigantism (X-LAG) syndrome.

Similar articles

  • [Old phenotype and new genotypes. Pituitary adenomas].
    Gérard C, Jedidi H, Petrossians P, Krzesinski F, Daly A, Beckers A. Gérard C, et al. Rev Med Liege. 2015 Nov;70(11):569-74. Rev Med Liege. 2015. PMID: 26738269 French.
  • Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients.
    Rostomyan L, Daly AF, Petrossians P, Nachev E, Lila AR, Lecoq AL, Lecumberri B, Trivellin G, Salvatori R, Moraitis AG, Holdaway I, Kranenburg-van Klaveren DJ, Chiara Zatelli M, Palacios N, Nozieres C, Zacharin M, Ebeling T, Ojaniemi M, Rozhinskaya L, Verrua E, Jaffrain-Rea ML, Filipponi S, Gusakova D, Pronin V, Bertherat J, Belaya Z, Ilovayskaya I, Sahnoun-Fathallah M, Sievers C, Stalla GK, Castermans E, Caberg JH, Sorkina E, Auriemma RS, Mittal S, Kareva M, Lysy PA, Emy P, De Menis E, Choong CS, Mantovani G, Bours V, De Herder W, Brue T, Barlier A, Neggers SJ, Zacharieva S, Chanson P, Shah NS, Stratakis CA, Naves LA, Beckers A. Rostomyan L, et al. Endocr Relat Cancer. 2015 Oct;22(5):745-57. doi: 10.1530/ERC-15-0320. Epub 2015 Jul 17. Endocr Relat Cancer. 2015. PMID: 26187128 Free PMC article. Clinical Trial.
  • Genetics of gigantism and acromegaly.
    Hannah-Shmouni F, Trivellin G, Stratakis CA. Hannah-Shmouni F, et al. Growth Horm IGF Res. 2016 Oct-Dec;30-31:37-41. doi: 10.1016/j.ghir.2016.08.002. Epub 2016 Aug 10. Growth Horm IGF Res. 2016. PMID: 27657986 Free PMC article. Review.
  • Screening for genetic causes of growth hormone hypersecretion.
    Rostomyan L, Beckers A. Rostomyan L, et al. Growth Horm IGF Res. 2016 Oct-Dec;30-31:52-57. doi: 10.1016/j.ghir.2016.10.004. Epub 2016 Oct 12. Growth Horm IGF Res. 2016. PMID: 27756606 Review.
  • Spontaneous remission of acromegaly or gigantism due to subclinical apoplexy of pituitary growth hormone adenoma.
    Wang XL, Dou JT, Lü ZH, Zhong WW, Ba JM, Jin D, Lu JM, Pan CY, Mu YM. Wang XL, et al. Chin Med J (Engl). 2011 Nov;124(22):3820-3. Chin Med J (Engl). 2011. PMID: 22340248
See all similar articles

Cited by 4 articles

Substances

Supplementary concepts

LinkOut - more resources

Feedback